×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ASMB – assembly biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ASMB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/8
04:05 pm
asmb
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Re
Low
Report
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Re
11/20
10:59 am
asmb
Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.
11/10
04:58 pm
asmb
Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]
Medium
Report
Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]
11/10
04:19 pm
asmb
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]
Medium
Report
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]
11/10
04:05 pm
asmb
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
Medium
Report
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
11/7
08:00 am
asmb
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
Low
Report
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
10/24
12:16 pm
asmb
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/14
08:08 am
asmb
Assembly Biosciences (NASDAQ:ASMB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/8
04:18 pm
asmb
Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 08
Low
Report
Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 08
12/8
11:43 am
asmb
Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: JANUS HENDERSON GROUP PLC
11/24
11:26 am
asmb
Form EFFECT ASSEMBLY BIOSCIENCES,
Low
Report
Form EFFECT ASSEMBLY BIOSCIENCES,
11/21
04:47 pm
asmb
Form 424B3 ASSEMBLY BIOSCIENCES,
Low
Report
Form 424B3 ASSEMBLY BIOSCIENCES,
11/10
04:16 pm
asmb
Form 10-Q ASSEMBLY BIOSCIENCES, For: Sep 30
Medium
Report
Form 10-Q ASSEMBLY BIOSCIENCES, For: Sep 30
11/10
04:11 pm
asmb
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 10
Medium
Report
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 10
10/3
04:30 pm
asmb
Form 4 ASSEMBLY BIOSCIENCES, For: Aug 08 Filed by: GILEAD SCIENCES, INC.
Medium
Report
Form 4 ASSEMBLY BIOSCIENCES, For: Aug 08 Filed by: GILEAD SCIENCES, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/12
Assembly Biosciences Announces Pricing of $125 Million Public Offering
41.6%
10/15 Assembly Biosciences Inc (NASDAQ: ASMB) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 36.7%
8/7 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer 20.2%
10/16 Here's Why Assembly Biosciences Stock Soared Today [The Motley Fool] 19.3%
9/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 16.2%
4/6 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy 12.3%
7/1 Assembly Biosciences Inc (NASDAQ: ASMB) had its "hold" rating re-affirmed by analysts at Chardan Capital. 9.8%
3/13 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 9.6%
3/26 Form SEC STAFF LETTER ASSEMBLY BIOSCIENCES, 9.2%
6/24 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 7.4%
10/15 Assembly Biosciences Inc (NASDAQ: ASMB) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 36.7%
8/7 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer 20.2%
10/16 Here's Why Assembly Biosciences Stock Soared Today [The Motley Fool] 19.3%
9/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 16.2%
4/6 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy 12.3%
7/1 Assembly Biosciences Inc (NASDAQ: ASMB) had its "hold" rating re-affirmed by analysts at Chardan Capital. 9.8%
3/13 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 9.6%
3/26 Form SEC STAFF LETTER ASSEMBLY BIOSCIENCES, 9.2%
6/24 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 7.4%
TOP News Decliners
11/11
Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019
-18.2%
10/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -11.0%
12/12 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.6%
8/9 Form 8-K ASSEMBLY BIOSCIENCES, For: Aug 06 -10.1%
9/24 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.8%
9/27 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. -7.7%
12/13 Form 424B5 ASSEMBLY BIOSCIENCES, -6.1%
5/10 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: EcoR1 Capital, LLC -4.9%
2/14 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC -3.9%
6/21 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China -3.6%
10/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -11.0%
12/12 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.6%
8/9 Form 8-K ASSEMBLY BIOSCIENCES, For: Aug 06 -10.1%
9/24 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.8%
9/27 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. -7.7%
12/13 Form 424B5 ASSEMBLY BIOSCIENCES, -6.1%
5/10 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: EcoR1 Capital, LLC -4.9%
2/14 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC -3.9%
6/21 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: